(Q39574128)

13 September 2017

title

Expression of EGFR and LRIG proteins in oesophageal carcinoma with emphasis on patient survival and cellular chemosensitivity (English)

1 reference

13 September 2017

1 reference

Xuping Wu

1

1 reference

13 September 2017

Håkan Hedman

2

1 reference

13 September 2017

Michael Bergqvist

3

1 reference

13 September 2017

Stefan Bergström

4

1 reference

13 September 2017

Roger Henriksson

5

1 reference

13 September 2017

Joachim Gullbo

6

1 reference

13 September 2017

Johan Lennartsson

7

1 reference

13 September 2017

Patrik Hesselius

8

1 reference

13 September 2017

Simon Ekman

9

1 reference

13 September 2017

language of work or name

1 reference

18 March 2011

1 reference

13 September 2017

1 reference

13 September 2017

volume

51

1 reference

13 September 2017

issue

1

1 reference

13 September 2017

page(s)

69-76

1 reference

Radiotherapy alone and chemoradiation for nonmetastatic esophageal carcinoma. A critical review of chemoradiation

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.562239

The ErbB receptors and their ligands in cancer: an overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.562239

Expression of epidermal growth factor, transforming growth factor alpha and their receptor in gastro-oesophageal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.562239

ZD1839 (Gefitinib, 'Iressa'), an epidermal growth factor receptor-tyrosine kinase inhibitor, enhances the anti-cancer effects of TRAIL in human esophageal squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.562239

Characterization and tissue-specific expression of human LRIG2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.562239

Perinuclear leucine-rich repeats and immunoglobulin-like domain proteins (LRIG1-3) as prognostic indicators in astrocytic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.562239

cDNA cloning of a novel membrane glycoprotein that is expressed specifically in glial cells in the mouse brain. LIG-1, a protein with leucine-rich repeats and immunoglobulin-like domains

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.562239

LRIG inhibitors of growth factor signalling - double-edged swords in human cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.562239

The leucine-rich repeat protein LRIG1 is a negative regulator of ErbB family receptor tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.562239

LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.562239

LRIG1 is a novel negative regulator of the Met receptor and opposes Met and Her2 synergy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.562239

Lrig1 is an endogenous inhibitor of Ret receptor tyrosine kinase activation, downstream signaling, and biological responses to GDNF.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.562239

LRIG1 and epidermal growth factor receptor in renal cell carcinoma: a quantitative RT--PCR and immunohistochemical analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.562239

Cytoplasmic LRIG2 expression is associated with poor oligodendroglioma patient survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.562239

Cloning, characterization, and expression of human LIG1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.562239

The LRIG gene family has three vertebrate paralogs widely expressed in human and mouse tissues and a homolog in Ascidiacea

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.562239

Down-regulation of leucine-rich repeats and immunoglobulin-like domain proteins (LRIG1-3) in HP75 pituitary adenoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.562239

Evaluation of prognostic factors of esophageal squamous cell carcinoma (stage II-III) after concurrent chemoradiotherapy using biopsy specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.562239

EGFR gene alterations as a prognostic biomarker in advanced esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.562239

LRIG1 negatively regulates the oncogenic EGF receptor mutant EGFRvIII.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.562239

Acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancers dependent on the epidermal growth factor receptor pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2011.562239

10.3109/0284186X.2011.562239

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference